As such, YAP/TAZ-dependent control of glutaminolysis may act as a central mechanism of the pulmonary vascular dysfunction induced by the change of the extracellular environment in PAH (Figure 1) (33). The gene discussed is WWTR1; the disease is pulmonary arterial hypertension.